… to the development of the Parkinson disease technical brief. WHO gratefully acknowledges
… technical input in the development of this technical brief: Maria Barretto, Parkinson’s Disease …

… These data provide important information concerning target identification for ablative or
deep brain stimulation procedures in idiopathic Parkinson's disease and other movement …

… The primary outcome was motor function on stimulation/off medication using the Unified
Parkinson's Disease Rating Scale motor subscale. Secondary outcomes included quality of life …

Parkinson disease (PD) is an age-related neurodegenerative disorder that affects as many
as 1–2% of persons aged 60 years and older. With the aging of the population, the frequency …

Remote and objective assessment of the motor symptoms of Parkinson’s disease is an area
of great interest particularly since the COVID-19 crisis emerged. In this paper, we focus on a) …

Many claims have been made regarding the efficacy of surgery for PD, but remarkably little
evidence comes from properly designed controlled clinical trials. In this review, the available …

… Parkinson disease (PD) is a heterogeneous multisystem neurodegenerative disorder with
a … The full text of this article hosted at iucr.org is unavailable due to technical difficulties. …

… In young, cognitively intact individuals with Parkinson disease, anticholinergic agents may
… across Parkinson disease stages. With progression, individuals with Parkinson disease will …

… Based on the above-mentioned examples, we expect effective technical solutions to
measure specific PD features for clinical management in either a standardized laboratory or …

… All of them identified by their treating neurologist as having idiopathic PD according to
UK Parkinson's Disease Society Brain Bank Diagnostic Criteria 10 were approached for …